GLPwatch
Trials (2167)
Page 30 of 37.
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
- A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
- Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
- Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
- Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
- Closed Loop System With Pramlintide Versus Exenatide
- A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
- Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
- Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes
- Clinical Outcomes of Exenatide Versus Basal Insulin
- Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)
- Coronary Flow Reserve Changes After Semaglutide Treatment
- Special Use - Results Surveillance on Long-term Use With Wegovy®
- The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
- Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
- A Retrospective Real-World Cohort Study
- Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels
- Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
- Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid
- Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
- Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
- A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
- The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide
- A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
- Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
- Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
- Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
- Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
- A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
- Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
- A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
- Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
- A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function
- Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study
- Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
- Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
- Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
- A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Extension Study for 2993-112
- A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
- Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes
- Bioenergetic Alterations After Exenatide Administration
- Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
- Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
- To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
- GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
- Exenatide Once-weekly as a Treatment for Multiple System Atrophy
- A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
- Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
- A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
- A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
- Obesity Treatment to Improve Diabetes
- Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
- Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
- A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations